Evidence map›Paper›PMID 35906423›Full record

SynthesisClinical research in cardiology : official journal of the German Cardiac Society2022

COVID-19 vaccination and carditis in children and adolescents: a systematic review and meta-analysis.

Oscar Hou In Chou, Jonathan Mui, Cheuk To Chung, Danny Radford, Simon Ranjithkumar, Endurance Evbayekha, Ronald Nam, Levent Pay, Danish Iltaf Satti, Sebastian Garcia-Zamora and 11 more

Open access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Clinical research in cardiology : official journal of the German Cardiac Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for new-onset gastric cancer and gastric diseases in patients with type 2 diabetes mellitus: a population-based cohort study.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2024
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 10 institutions in 5 countries.

Oscar Hou In Chou *Epidemiology Research Unit, Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong, China.
Jonathan Mui *Epidemiology Research Unit, Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong, China.
Cheuk To ChungEpidemiology Research Unit, Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong, China.
Danny RadfordEpidemiology Research Unit, Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong, China.
Simon RanjithkumarFaculty of Health and Life Sciences, Aston University Medical School, Birmingham, B4 7ET, UK.
Endurance EvbayekhaEpidemiology Research Unit, Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong, China.
Ronald NamEpidemiology Research Unit, Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong, China.
Levent PayDepartment of Cardiology, Dr Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, 34668, Istanbul, Turkey.
Danish Iltaf SattiEpidemiology Research Unit, Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong, China.
Sebastian Garcia-ZamoraCardiac Intensive Care Unit, Department of Cardiology, Delta Clinic, Rosario, Santa Fe, Argentina.
George BazoukisDepartment of Cardiology, Medical School, University of Nicosia, 2408, Nicosia, Cyprus.
Göksel ÇinierDepartment of Cardiology, Dr Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, 34668, Istanbul, Turkey.
Sharen LeeEpidemiology Research Unit, Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong, China.
Vassilios S VassiliouDepartment of Medicine, Bob Champion Research and Education, Norwich Medical School, University of East Anglia and Norfolk and Norwich University Hospital, Rosalind Franklin Rd, Norwich, NR4 7UQ, UK. v.vassiliou@uea.ac.uk.
Tong LiuTianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China. liutongdoc@126.com.
Gary TseTianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China. gary.tse@kmms.ac.uk.ORCID http://orcid.org/0000-0001-5510-1253
Ian Chi Kei WongResearch Department of Practice and Policy, School of Pharmacy, University College London, London, UK.
Cardiovascular Analytics Group, the International Health Informatics Study Network
Oscar Hou In Chou
Tong Liu
Gary Tse
Aston University · GBDr. Siyami Ersek Göğüs Kalp Ve Damar Cerrahisi Eğitim Ve Araştırma Hastanesi · TRSecond Hospital of Tianjin Medical University · CNUniversity of London · GBCanterbury Christ Church University · GBInstituto Cardiovascular de Rosario · ARMedway School of Pharmacy · GBUniversity College London · GBUniversity of East Anglia · GBUniversity of Nicosia · CY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCoronavirus Disease-2019 (COVID-19) vaccination has been associated with the development of carditis, especially in children and adolescent males. However, the rates of these events in the global setting have not been explored in a systematic manner. The aim of this systematic review and meta-analysis is to investigate the rates of carditis in children and adolescents receiving COVID-19 vaccines.

methodsPubMed, Embase and several Latin American databases were searched for studies. The number of events, and where available, at-risk populations were extracted. Rate ratios were calculated and expressed as a rate per million doses received. Subgroup analysis based on the dose administered was performed. Subjects ≤ 19 years old who developed pericarditis or myocarditis following COVID-19 vaccination were included.

resultsA total of 369 entries were retrieved. After screening, 39 articles were included. Our meta-analysis found that 343 patients developed carditis after the administration of 12,602,625 COVID-19 vaccination doses (pooled rate per million: 37.76; 95% confidence interval [CI] 23.57, 59.19). The rate of carditis was higher amongst male patients (pooled rate ratio: 5.04; 95% CI 1.40, 18.19) and after the second vaccination dose (pooled rate ratio: 5.60; 95% CI 1.97, 15.89). In 301 cases of carditis (281 male; mean age: 15.90 (standard deviation [SD] 1.52) years old) reported amongst the case series/reports, 261 patients were reported to have received treatment. 97.34% of the patients presented with chest pain. The common findings include ST elevation and T wave abnormalities on electrocardiography. Oedema and late gadolinium enhancement in the myocardium were frequently observed in cardiac magnetic resonance imaging (CMR). The mean length of hospital stay was 3.91 days (SD 1.75). In 298 out of 299 patients (99.67%) the carditis resolved with or without treatment.

conclusionsCarditis is a rare complication after COVID-19 vaccination across the globe, but the vast majority of episodes are self-limiting with rapid resolution of symptoms within days. Central illustration. Balancing the benefits of vaccines on COVID-19-caused carditis and post-vaccination carditis.

Indexed as

COVID-19COVID-19 VaccinesMyocarditisVaccinesAdolescentAdultChildContrast MediaGadoliniumHumansInfantMaleVaccinationYoung AdultContrast MediaCOVID-19 VaccinesGadoliniumVaccinesCarditisCOVID-19MyocarditisPericarditisVaccine

Identifiers

PMID35906423
PMCPMC9361966
OpenAlexW4288684895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.